You are here

Drug industry faces era of moderate price increases, says Valeant CEO

New York

VALEANT Pharmaceuticals International, which has been criticised for raising drug prices and is being investigated by the US government, predicted this week that lower price increases are ahead for the whole industry.

Valeant chief executive J Michael Pearson told